Evidence map›Paper›PMID 42216154›Full record

ArticleBMC endocrine disorders2026

Time to resolution of diabetic ketoacidosis in children with type 1 diabetes: a survival analysis of clinical predictors.

Ahmed Ketema Abegaz, Asnakew Molla Mekonen, Robel Asaminew Mekonnen, Amare Muche

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmed Ketema AbegazDepartment of Pediatrics and Child Health, School of Medicine, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Asnakew Molla MekonenDepartment of Health System and Management, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Robel Asaminew MekonnenDepartment of Pediatrics and Child Health, School of Medicine, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Amare MucheDepartment of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia. amaremu7@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic ketoacidosis (DKA) is one of the most serious acute complications of diabetes mellitus in children, often leading to severe dehydration, altered consciousness, and death if not promptly managed. The burden of DKA is increasing globally and in Ethiopia, placing substantial strain on pediatric emergency and inpatient care services. Despite its clinical and public health importance, evidence on time to resolution of DKA and its predictors remains limited in Ethiopia, particularly in the northeastern region. This study aimed to assess the time to resolution of DKA and its predictors in children with type 1 diabetes.

methodsA retrospective follow-up study was conducted using 494 medical records of children with type 1 diabetes mellitus treated at Dessie Comprehensive Specialized Hospital between January 1, 2020, and December 31, 2024. Patient charts were selected using a simple random sampling technique. Data were extracted through a structured checklist based on registry and medical chart reviews. Kaplan-Meier survival analysis was employed to estimate time to resolution from DKA, and differences in survival distributions across categories of explanatory variables were assessed using the log-rank test. Cox proportional hazards regression was applied to identify predictors of time to resolution of DKA. Variables with a p-value < 0.25 in the bivariable analysis were included in the multivariable Cox regression model, adjusted hazard ratio (AHR) with its 95% confidence interval and p-value ≤ 0.05 in the multivariable analysis were considered statistically significant.

resultsA total of 487 children were followed for 12,279 person-hours of observation. Of these, 406 children recovered, yielding a resolution proportion of 83.37% (95% CI: 80.06-86.67), while 81 (16.63%) were censored during the follow-up period. The overall incidence rate of resolution from DKA was 3.30 per 100 person-hours (95% CI: 2.99-3.64), with a median time to resolution of 22 h (95% CI: 18.32-25.67). In the multivariable Cox regression analysis, baseline random blood sugar (RBS) levels > 500 mg/dL (AHR = 0.77; 95% CI: 0.62-0.96), presence of infection (AHR = 0.65; 95% CI: 0.47-0.90), newly diagnosed diabetes mellitus (AHR = 0.79; 95% CI: 0.63-0.99 and DKA duration ≥ 24 h (AHR = 0.08; inverse of < 24 h) were associated with a longer time to resolution of DKA. Conversely, mild DKA (AHR = 1.37; 95% CI: 1.01-1.84) and DKA duration < 24 h (AHR = 11.96; 95% CI: 7.71-18.55) were significantly associated with a shorter time to resolution of DKA. CONCLUSION AND RECOMMENDATIONS: The study identified a relatively prolonged resolution time of DKA among children in the study area. Baseline random blood sugar level > 500 mg/dL, presence of infection and newly diagnosed diabetes had negative relationship (delayed resolution) while mild DKA severity, and duration of DKA < 24 h had positive relationship (faster resolution). These findings highlight the need for healthcare providers and caregivers to address these factors to accelerate resolution and improve clinical outcomes.

trial registrationClinical trial number: Not applicable.

Indexed as

Diabetes Mellitus, Type 1Diabetic KetoacidosisAdolescentChildChild, PreschoolEthiopiaFemaleFollow-Up StudiesHumansMalePrognosisRetrospective StudiesSurvival AnalysisTime FactorsChildrenCox proportional hazardsDiabetic ketoacidosisEthiopiaPredictorsResolution timeType 1 diabetes

Identifiers

PMID42216154
PMCPMC13435390

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.